Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure

Circulation

Volumn 114, Issue SUPPL. 1, 2006, Pages

  Woo, Y Joseph ^a,c   Panlilio, Corinna M ^a   Cheng, Richard K ^b   Liao, George P ^a   Atluri, Pavan ^a   Hsu, Vivian M ^a   Cohen, Jeffrey E ^a   Chaudhry, Hina W ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Columbia University School of Medicine ^*  (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cyclin; Heart failure; Myocardial regeneration

Indexed keywords

ADENOVIRUS VECTOR; BROXURIDINE; CYCLIN A; CYCLINE; HISTONE H3; KI 67 ANTIGEN; CCNA2 PROTEIN, MOUSE; HYBRID PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CELL CYCLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DNA SYNTHESIS; GENE TRANSFER; GEOMETRY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART OUTPUT; HEART PRELOAD; HEART VENTRICLE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MITOSIS; MYOFILAMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGENERATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WESTERN BLOTTING; ADENOVIRUS; ANIMAL; CELL DIVISION; CONGESTIVE HEART FAILURE; CYTOLOGY; DEFECTIVE VIRUS; DNA REPLICATION; EVALUATION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEART; HEART INFARCTION; HEART MUSCLE; INJECTION; LEWIS RAT; METABOLISM; MICROFILAMENT; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; ULTRASTRUCTURE;

ADENOVIRIDAE; ANIMALS; CELL CYCLE; CELL DIVISION; CYCLIN A; DEFECTIVE VIRUSES; DNA REPLICATION; GENETIC VECTORS; HEART; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; INJECTIONS; MALE; MICE; MICROFILAMENTS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS; REGENERATION; TRANSDUCTION, GENETIC;

EID: 33747180560     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.000455     Document Type: Article

References (33)

1. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003;100:12313-12318.
2. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, Sano M, Toko H, Akazawa H, Sato T, Nakaya H, Kasanuki, H, Komuro I. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004;279:11384-11391.
3. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
4. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, Goetsch SC, Gallardo TD, Garry DJ. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol. 2004;265:262-275.
5. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S, Chien KR. Postnatal is11+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature. 2005;433:647-653.
6. Bicknell KA, Coxon CH, Brooks G. Forced expression of the cyclin B1-CDC2 complex induces proliferation in adult rat cardiomyocytes. Biochem J. 2004;382(Pt 2):411-416.
7. Regula KM, Rzeszutek MJ, Baetz D, Seneviratne C, Kirshenbaum LA. Therapeutic opportunities for cell cycle re-entry and cardiac regeneration. Cardiovasc Res. 2004;64:395-401.
8. Regula KM, Kirshenbaum LA. Breaking down cell-cycle barriers in the adult heart. Circ Res. 2004;94:1524-1526.
9. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res.1998;83:15-26.
10. Brooks G, Poolman RA, McGill CJ, Li JM. Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes. J Mol Cell Cardiol. 1997;29:2261-2271.
11. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res. 2005;96(1):110-8.
12. Li JM, Poolman RA, Brooks G. Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats. Am J Physiol. 1998;275:H814-H22.
13. Chaudhry HW, Dashoush NH, Tang H, Zhang L, Wang X, Wu EX, Wolgemuth DJ. Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J Biol Chem. 2004;279:35858-35866.
14. Jayasankar V, Woo YJ, Bish LT, Pirolli TJ, Chatterjee S, Berry MF, Burdick J, Gardner TJ, Sweeney HL. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation. 2003;108(Suppl 1):II230-II236.
15. Woo YJ, Grand TJ, Berry MF, Atluri P, Moise MA, Hsu VM, Cohen J, Fisher O, Burdick J, Taylor M, Zentko S, Liao G, Smith M, Kolakowski S, Jayasankar V, Gardner TJ, Sweeney HL. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2005;130:321-329.
16. Liu YH, Yang XP, Nass O, Sabbah HB, Peterson E, Carretero OA. Chronic heart failure induced coronary artery ligation in Lewis inbred rats. Am J Physiol. 1997;272:H722-H727.
17. Jayasankar V, Woo YJ, Bish LT, Pirolli TJ, Berry MF, Burdick J, Bhalla RC, Sharma RV, Gardner TJ, Sweeney HL. Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy. Circulation. 2004;110(11 Suppl 1):II180-II186.
18. Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ, Woo YJ. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation. 2004 Sep 14;110(11 Suppl 1):II1870-II193.
19. Jayasankar V, Bish LT, Pirolli TJ, Berry MF, Burdick J, Woo YJ. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function. Ann Thorac Surg. 2004;77:2122-2129.
20. Woo YJ, Taylor MD, Cohen JE, Jayasankar V, Bish LT, Burdick J, Pirolli TJ, Berry MF, Hsu V, Grand T. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. J Thorac Cardiovasc Surg. 2004;127:1262-1269.
21. Agah R, Kirshenbaum LA, Abdellatif M, et al. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest. 1997;100:2722-2728.
22. Poolman RA, Li JM, Durand B, Brooks G. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ Res. 1999;85:117-127.
23. Gill RM, Slack R, Kiess M, Hamel PA. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells. Exp Cell Res. 1998;244:157-170.
24. Yoshizumi M, Lee WS, Hsieh CM, Tsai JC, Li J, Perrella MA, Patterson C, Endege WO, Schlegel R, Lee ME. Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J Clin Invest. 1995;95:2275-2280.
25. Murphy M, Stinnakre MG, Senamaud-Beaufort C, Winston NJ, Sweeney C, Kubelka M, Carrington M, Brechot C, Sobczak-Thepot J. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat Genet. 1999;23:481-486.
26. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P. Mouse development and cell proliferation in the absence of D-cyclins. Cell. 2004;118:477-491.
27. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S, Dubus P, Barbacid M. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 2004;118:493-504.
28. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P. Cyclin E ablation in the mouse. Cell. 2003;114:431-443.
29. Li JM, Brooks G. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy? Eur Heart J Mar. 1999;20:406-420.
30. Wei Y, Mizzen CA, Cook RG, Gorovsky MA, Allis CD. Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena. Proc Natl Acad Sci U S A. 1998;95:7480-7484.
31. Tamamori-Adachi M, Ito H, Sumrejkanchanakij P, Adachi S, Hiroe M, Shimizu M, Kawauchi J, Sunamori M, Marumo F, Kitajima S, Ikeda MA. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ Res Jan 10. 2003;92:e12-e9.
32. Akli S, Zhan S, Abdellatif M, Shneider MD. E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2. Circ Res. 1999;85:319-328.
33. Suzuki G, Lee TC, Fallavollita JA, Canty JM Jr. Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle. Circ Res. 2005;96:767-775.